George Follows, MA, BM, BCh, PhD, FRCP, FRCPath from Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK discusses the lymphoid highlights from the 2017 British Society for Hematology (BSH) Annual Scientific Meeting in Brighton, UK. An extremely broad range of data werepresented this year all types of lymphoma and the novel drugs that are being trialed to treat them. Interesting data from the GALLIUM trial (NCT01332968) were presented at the conference that sparked debate regarding its results and how this will translate into clinical practice. The results from the chronic lymphocytic leukemia (CLL) forum data, a collaborative effort of UK hematologists, were extremely informative and demonstrated the effect of ibrutinib therapy, and the difference in survival outcomes for CLL patients who relapsed in the first year versus those who relapsed in the second year. This video has been supported by Napp Pharmaceuticals Ltd through an unrestricted educational grant to Magdalen Medical Publishing.
Get great new content delivered to your inboxSign up
By choosing to continue, you are confirming that you are a healthcare professional
Please enter your details if you would like to receive the latest Hemonc news and updates